T&R Biofab Co. Ltd - Asset Resilience Ratio

Latest as of September 2025: 0.12%

T&R Biofab Co. Ltd (246710) has an Asset Resilience Ratio of 0.12% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read T&R Biofab Co. Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

₩100.00 Million

≈ $67.77K USD Cash + Short-term Investments

Total Assets

₩83.86 Billion

≈ $56.83 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how T&R Biofab Co. Ltd's Asset Resilience Ratio has changed over time. See 246710 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down T&R Biofab Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 246710 stock market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩100.00 Million	0.12%
Total Liquid Assets	₩100.00 Million	0.12%

Asset Resilience Insights

Limited Liquidity: T&R Biofab Co. Ltd maintains only 0.12% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

T&R Biofab Co. Ltd Industry Peers by Asset Resilience Ratio

Compare T&R Biofab Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
INKON Life Technology Co Ltd SHE:300143	Medical Devices	3.37%
CareRay Digital Medical Technology Co Ltd SHG:688607	Medical Devices	16.21%
Senseonics Holdings, Inc. Common Stock NYSE MKT:SENS	Medical Devices	54.67%
Universus Photo Imagings Limited NSE:UNIVPHOTO	Medical Devices	30.97%
HansBiomed Corporation KQ:042520	Medical Devices	9.13%
Aligned Genetics Inc KQ:238120	Medical Devices	2.22%
Heramed Ltd AU:HMD	Medical Devices	0.83%
Acarix A/S ST:ACARIX	Medical Devices	37.81%

Annual Asset Resilience Ratio for T&R Biofab Co. Ltd (2016–2024)

The table below shows the annual Asset Resilience Ratio data for T&R Biofab Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	17.55%	₩17.28 Billion ≈ $11.71 Million	₩98.45 Billion ≈ $66.72 Million	-34.30pp
2023-12-31	51.84%	₩51.75 Billion ≈ $35.07 Million	₩99.82 Billion ≈ $67.64 Million	-1.39pp
2022-12-31	53.23%	₩40.42 Billion ≈ $27.39 Million	₩75.94 Billion ≈ $51.46 Million	-17.50pp
2021-12-31	70.73%	₩58.17 Billion ≈ $39.42 Million	₩82.23 Billion ≈ $55.73 Million	-5.30pp
2020-12-31	76.03%	₩36.88 Billion ≈ $24.99 Million	₩48.51 Billion ≈ $32.87 Million	-4.17pp
2019-12-31	80.20%	₩21.72 Billion ≈ $14.72 Million	₩27.09 Billion ≈ $18.36 Million	-11.94pp
2018-12-31	92.13%	₩28.66 Billion ≈ $19.42 Million	₩31.10 Billion ≈ $21.08 Million	+9.69pp
2017-12-31	82.44%	₩7.80 Billion ≈ $5.29 Million	₩9.47 Billion ≈ $6.42 Million	-1.57pp
2016-12-31	84.01%	₩8.06 Billion ≈ $5.46 Million	₩9.59 Billion ≈ $6.50 Million	--

pp = percentage points

About T&R Biofab Co. Ltd

KQ:246710 Korea Medical Devices

Market Cap

$61.19 Million

₩90.30 Billion KRW

Market Cap Rank

#21091 Global

#1319 in Korea

Share Price

₩2960.00

Change (1 day)

-2.95%

52-Week Range

₩1194.00 - ₩5530.00

All Time High

₩44150.00